Three IPOs, Three SPAC Mergers, But One Company Opted Out
Talaris, Valneva, Anebulo Make 43 US Biopharma IPOs In 2021
Three firms launched initial public offerings during the first week of May, but Gyroscope postponed its IPO while Jasper, Science 37 and Roivant took the special purpose acquisition corporation route.
